Anemija pri bolnikih z rakom

Breda Škrbinc (Author), Tanja Južnič Šetina (Author)

Abstract

Anemija ali slabokrvnost je bolezensko stanje, pri katerem je zmanjšana celotna masa eritrocitov v krvnem obtoku, zaradi česar se zmanjša tudi sposobnost krvi za prenos kisika. Glavni vzroki anemije so zmanjšana tvorba eritrocitov, povečana razgradnja eritrocitov in krvavitev. Anemija, ki se pojavlja pri 30 do 90 % bolnikov z rakom je navadno posledica kombinacije več vzrokov, najpogosteje vpliva citokinov, ki se sproščajo ob maligni bolezni in mielosupresivnega učinka specifičnega onkološkega zdravljenja. Anemijo tudi pri bolnikih z rakom opredelimo po standardnih diagnostičnih postopkih, zdravljenje pa je odvisno od bolnikovih simptomov, stopnje anemije, hitrosti njenega nastanka, spremljajočih bolezni in ciljev zdravljenja bolnika z rakom. Najpogosteje uporabljamo transfuzijo koncentriranih eritrocitov in rekombinantne eritropoetine (EPA).

Keywords

No keyword data available

Data

Language:	Slovenian
Year of publishing:	2010
Typology:	1.04 - Professional Article
Organization:	OI - Institute of Oncology
UDC:	616-006.6:616.15
COBISS:	968827
ISSN:	1408-1741
Parent publication:	Onkologija
Views:	2637
Downloads:	550
Average score:	0 (0 votes)
Metadata:

Other data

Secondary language:	English
Secondary title:	Anemia in Cancer Patients
Secondary abstract:	Anemia is defined as a significant reduction of the red cell mass and a corresponding decrease of the oxigen-carrying capacity of the blood. The etiology of anemia can be due to decreased red blood cell (RBC) production, increased RBC destruction and blood loss. Anemia is prevalent in 30-90 % of cancer patients with a number of factors that may contribute to its developement, most often overexpression of inflammatory cytokines accompanying malignant disease and mielosuppressive cancer treatment. Anemia in cancer patients should be identified by standard diagnostic procedures. Decision about treatment of cancer related anemia depends on the patient's symptoms, degree of anemia and the rate at which it has evolved, patient's comorbidities and the goal of cancer treatment in a certain patient. Management of anemia in cancer patients includes the transfusion of packed red blood cells and / or the administration of recombinant erythropoetin.
Secondary keywords:	Neoplasms;Anemia;Diagnosis;Therapy;
URN:	URN:NBN:SI
Pages:	str. 43-45
Volume:	ǂLeto ǂ14
Issue:	ǂšt. ǂ1
Chronology:	jun. 2010
ID:	10957233